Elez, E., Pericay, C., Valladares-Ayerbes, M., Bando, I., Safont, M. J., Gallego, J., . . . Aranda Aguilar, E. (2019). A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
Citación estilo ChicagoElez, Elena|||0000-0002-4653-6324, et al. A Phase 2 Study of Panitumumab With Irinotecan As Salvage Therapy in Chemorefractory KRAS Exon 2 Wild-type Metastatic Colorectal Cancer Patients. 2019.
Cita MLAElez, Elena|||0000-0002-4653-6324, et al. A Phase 2 Study of Panitumumab With Irinotecan As Salvage Therapy in Chemorefractory KRAS Exon 2 Wild-type Metastatic Colorectal Cancer Patients. 2019.
Precaución: Estas citas no son 100% exactas.